Cas:1319-46-6 Basic lead carbonate manufacturer & supplier

We serve Chemical Name:Basic lead carbonate CAS:1319-46-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Basic lead carbonate

Chemical Name:Basic lead carbonate
CAS.NO:1319-46-6
Synonyms:Lead(2+) carbonate hydroxide (3:2:2);MFCD00078155;Lead subcarbonate;Cerussa;Lead carbonate bosic;Flake lead;EINECS 215-290-6;CI pigment white 1;Lead carbonate hydroxide;Lead(II) Carbonate Basic;White lead;Ceruse
Molecular Formula:C2H2O8Pb3
Molecular Weight:775.63200
HS Code:

Physical and Chemical Properties:
Melting point:400 °C (dec.)(lit.)
Boiling point:333.6ºC at 760 mmHg
Density:6,14 g/cm3
Index of Refraction:
PSA:166.84000
Exact Mass:777.90500
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2291 6.1/PG 3
Packing Group:III


Contact us for information like Lead(2+) carbonate hydroxide (3:2:2) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ceruse physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,White lead Use and application,Lead(2+) carbonate hydroxide (3:2:2) technical grade,usp/ep/jp grade.


Related News: AstraZeneca’s application for anifrolumab in SLE is under review by regulatory authorities in the US, EU and Japan, with decisions anticipated in the second half of 2021. Anifrolumab is not currently approved in any country. 1-ethyl-2-oxo-2,3-dihydro-1H-benzoimidazole-5-carboxylic acid manufacturers But one clear concern among the CDC’s expert group this time around was the rapidly spreading Delta variant, first found in India. That mutated strain now accounts for over 80% of new U.S. infections that are sequenced, CDC data shows. (2S,3S,4S,5R)-3,5-dihydroxy-2,4-dimethyl-1-((4-methoxybenzyl)oxy)oct-6-ene suppliers The FDA in announcing its approval noted that four, 12-week placebo-controlled clinical studies that included a total of 1,143 participants showed Nourianz offered a statistically significant decrease from baseline in daily “off” time compared to those on placebo. 4-(1,1-dimethylethylthio)-1-butyllithium vendor & factory.